Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Lingxi Xing

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5024871579. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 3 papers · 2017: 1 paper

Papers 4

  1. Role of microenvironmental periostin in pancreatic cancer progression. Co-author DOI 10.18632/oncotarget.11533↗
  2. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Co-author DOI 10.1007/s13277-016-5321-6↗
  3. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. Co-author DOI 10.18632/oncotarget.9512↗
  4. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic … Co-author DOI 10.7150/thno.15164↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lizhou Lin · 4 shared papers, 2016–2017 · strength 0.23
  2. Lianfang Du · 3 shared papers, 2016–2017 · strength 0.17
  3. Feng Gao · 3 shared papers, 2016–2017 · strength 0.17
  4. Jiajie Zhang · 3 shared papers, 2016–2017 · strength 0.17
  5. Peng Qin · 3 shared papers, 2016–2017 · strength 0.17
  6. Fan Li · 3 shared papers, 2016–2017 · strength 0.17
  7. Yang Liu · 1 shared paper, 2017 · strength 0.06
  8. Lianfang Du · 1 shared paper, 2016 · strength 0.05
  9. Yang Liu · 1 shared paper, 2016 · strength 0.05
  10. Liu Yang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.